Medtech
The recent CBRE Research report, “2019 U.S. Life Sciences Clusters” has two Texas metropolitan areas in its top-10 fastest-growing life sciences market. Houston ranked third, while Dallas/Ft. Worth ranked seventh. Let’s look at Dallas/Ft. Worth.
Independent Public Clinical Hospital No. 4 in Lublin is the first hospital outside of Germany to offer NanoTherm Therapy for the treatment of brain tumor patients
Public perception of the industry can be a bit confusing. Life Science Leader recently pulled together several biopharma executives for a round table discussion of the biopharma industry’s public perception—generally bad—and what might be able to do about it.
A recent report by CBRE Research analyzing U.S. life science clusters, found that Houston, Texas is the third-fastest growing life science market from 2014 to 2017. One doesn’t typically think of Texas, let alone Houston, as being a center for the life sciences. Oil, energy and tech, yes, but not life sciences.
Good safety profile and encouraging efficacy reported for recurrent glioblastoma patients with disrupted blood-brain barrier
The vast majority of Americans are happy at their jobs, according to a new survey conducted by CNBC and Survey Monkey. A BioSpace poll shows that a lot of people in the life sciences industries are not happy at work.
According to a recent BioSpace survey, 69% of employers indicated “finding quality talent” will be a significant challenge in 2019. Are you the quality talent life science employers are looking for? Don’t delay, apply now and show these employers you possess the quality skills they need!
A U.S. Food and Drug Administration (FDA) advisory panel voted 14 to 0 against recommending Neuronix’s NeuroAD system for the treatment of mild to moderate Alzheimer’s disease.
Researchers at the Rochester Institute of Technology have developed a toilet seat with biometric sensors in it. The primary purpose (the Number 1 purpose?) is to monitor an individual’s cardiovascular system.
First hospital outside of Germany to offer MagForce’s NanoTherm therapy for the commercial treatment of brain tumor patients
PRESS RELEASES